Personalized paroxysmal atrial fibrillation ablation by tailoring ablation index to the left atrial wall thickness: the ‘Ablate by-LAW’ single-centre study—a pilot study

医学 心房颤动 烧蚀 肺静脉 透视 心脏病学 内科学 导管消融 人口 阵发性心房颤动 并发症 放射科 核医学 外科 环境卫生
作者
Cheryl Terés,David Soto‐Iglesias,Diego Penela,Beatriz Jáuregui,Augusto Ordóñez,Alfredo Chauca,José Miguel Carreño,Claudia Scherer,Rodolfo San Antonio,Marina Huguet,Albert Roque,Carlos Felipe Barrera-Ramírez,Guillermo Oller,A Jornet,Jordi Palet,David Santana,Alejandro Panaro,Giuliana Maldonado,Gustavo De León,Gustavo Jiménez,Arturo Evangelista,Julio Carballo,Jose T. Ortiz‐Pérez,Antonio Berruezo
出处
期刊:Europace [Oxford University Press]
卷期号:24 (3): 390-399 被引量:42
标识
DOI:10.1093/europace/euab216
摘要

To determine if adapting the ablation index (AI) to the left atrial wall thickness (LAWT), which is a determinant of lesion transmurality, is feasible, effective, and safe during paroxysmal atrial fibrillation (PAF) ablation.Consecutive patients referred for PAF first ablation. Left atrial wall thickness three-dimensional maps were obtained from multidetector computed tomography and integrated into the CARTO navigation system. Left atrial wall thickness was categorized into 1 mm layers and AI was titrated to the LAWT. The ablation line was personalized to avoid thicker regions. Primary endpoints were acute efficacy and safety, and freedom from atrial fibrillation (AF) recurrences. Follow-up (FU) was scheduled at 1, 3, 6, and every 6 months thereafter. Ninety patients [60 (67%) male, age 58 ± 13 years] were included. Mean LAWT was 1.25 ± 0.62 mm. Mean AI was 366 ± 26 on the right pulmonary veins with a first-pass isolation in 84 (93%) patients and 380 ± 42 on the left pulmonary veins with first-pass in 87 (97%). Procedure time was 59 min (49-66); radiofrequency (RF) time 14 min (12.5-16); and fluoroscopy time 0.7 min (0.5-1.4). No major complication occurred. Eighty-four out of 90 (93.3%) patients were free of recurrence after a mean FU of 16 ± 4 months.Personalized AF ablation, adapting the AI to LAWT allowed pulmonary vein isolation with low RF delivery, fluoroscopy, and procedure time while obtaining a high rate of first-pass isolation, in this patient population. Freedom from AF recurrences was as high as in more demanding ablation protocols. A multicentre trial is ongoing to evaluate reproducibility of these results.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
香蕉觅云应助入暖采纳,获得10
1秒前
夏夏完成签到,获得积分10
1秒前
1秒前
小守城完成签到,获得积分10
2秒前
Lemuel完成签到,获得积分10
3秒前
郑小传完成签到,获得积分10
3秒前
lixuan完成签到,获得积分10
3秒前
3秒前
WANGCHU完成签到,获得积分20
3秒前
多看文献完成签到,获得积分10
4秒前
4秒前
怕黑的音响完成签到 ,获得积分10
4秒前
5秒前
Crystal完成签到,获得积分10
5秒前
5秒前
ivying0209完成签到,获得积分10
6秒前
盛夏完成签到,获得积分20
6秒前
Orange应助牵墨采纳,获得10
7秒前
7秒前
杨半鬼发布了新的文献求助10
7秒前
lxl完成签到,获得积分10
8秒前
8秒前
洛尘完成签到,获得积分10
8秒前
Xingruxiao完成签到,获得积分10
8秒前
淳之风完成签到,获得积分10
8秒前
jiwn完成签到,获得积分10
8秒前
8秒前
甜蜜高丽完成签到 ,获得积分10
9秒前
zxj完成签到 ,获得积分10
9秒前
maomao完成签到,获得积分10
9秒前
有运气的老年人完成签到,获得积分10
9秒前
LeungYM完成签到 ,获得积分10
9秒前
black的hole完成签到,获得积分10
9秒前
9秒前
12完成签到,获得积分10
10秒前
欣喜的诗筠完成签到 ,获得积分10
10秒前
10秒前
jxxxxxx完成签到,获得积分10
10秒前
Lchemistry完成签到,获得积分10
11秒前
Tau发布了新的文献求助30
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of Milkfat Fractionation Technology and Application, by Kerry E. Kaylegian and Robert C. Lindsay, AOCS Press, 1995 1000
A novel angiographic index for predicting the efficacy of drug-coated balloons in small vessels 500
Textbook of Neonatal Resuscitation ® 500
The Affinity Designer Manual - Version 2: A Step-by-Step Beginner's Guide 500
Affinity Designer Essentials: A Complete Guide to Vector Art: Your Ultimate Handbook for High-Quality Vector Graphics 500
Optimisation de cristallisation en solution de deux composés organiques en vue de leur purification 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5080327
求助须知:如何正确求助?哪些是违规求助? 4298282
关于积分的说明 13390804
捐赠科研通 4121842
什么是DOI,文献DOI怎么找? 2257344
邀请新用户注册赠送积分活动 1261652
关于科研通互助平台的介绍 1195768